WE ARE A MULTIDISCIPLINARY TEAM OF WORLD-CLASS SCIENTISTS, ENGINEERS, CLINICIANS, AND ENTREPRENEURS.
-
NINA TANDON
CEO, Co-Founder
Dr. Tandon bridges the realms of business and science, with over 20 years of experience in biomedical engineering. She completed two advanced degrees at Columbia University: a Ph.D. and postdoc in stem cells and tissue engineering and an Executive MBA in healthcare entrepreneurship. Named one of the 100 most creative people in business by Fast Company, she is also a TED Senior Fellow and MIT & McKinsey alum. Nina enjoys yoga, skiing, and spending time with her young family. Her TED Talk on personalized medicine has been viewed more than a million times.
-
SARINDR "IK" BHUMIRATANA
CSO, Co-Founder
Born and raised in Thailand, Dr. Bhumiratana (a.k.a. Ik) moved to the U.S. to pursue science. His PhD and postdoc at Columbia University focused on engineering bone, cartilage, and osteochondral tissues from stem cells. He now works to translate that innovation toward clinical use at EpiBone. Ik holds two patents and has authored four book chapters and more than 15 journal articles related to bone and cartilage tissue engineering. He enjoys rock climbing, snowboarding, & soccer.
BOARD OF DIRECTORS
-
ROBERT S. LANGER
Dr. Langer, the Lemelson-MIT prize winner for being one of history’s most prolific inventors in medicine, is one of 11 Institute Professors at the Massachusetts Institute of Technology, the highest honor that can be awarded to a faculty member. He has been elected to the National Academy of Medicine, the National Academy of Engineering, the National Academy of Sciences and the National Academy of Inventors. His over 220 awards include both the United States National Medal of Science and the United States National Medal of Technology and Innovation (he is one of 3 living individuals to have received both these honors) and holds 34 honorary doctorates from academic institutions across the globe.
-
GORDANA VUNJAK-NOVAKOVIC
A leading expert in tissue engineering, Dr. Vunjak-Novakovic focuses on engineering human tissues for regenerative medicine, stem cells, and disease modeling. She holds more than 70 patents and is a frequent advisor to government & industry. She is the Director of the Laboratory for Stem Cells & Tissue Engineering at Columbia University, and a member of the National Academy of Engineering, the Institute of Medicine of the National Academies, and the National Academy of Inventors.
-
DAVID ZHU
David Zhu is the Founding Partner of Kendall Capital Partners based in Boston, MA. Kendall Capital Partners invests in early-stage companies that are incubated by scientific labs from top universities. The firm led a venture round in EpiBone. David has extensive experience in venture investments and currently sits on the board of a number of private companies including Rejuvenate Bio, Omnipulse and Bilayer.
ADVISORS
-
Jim Gunton has invested in privately-held growth technology companies for more than 20 years. Before co-founding the $80 million NJTC Venture Fund in 2001, Jim was a partner at Edison Venture Fund and a manager at Oracle Corporation in Silicon Valley. He served formerly as a Governor of the National Association of Small Business Investment Companies, and has served on the board of numerous private and public companies including Achieve3000, Amber Road, CytoSorbents, InstaMed, IntegriChain and CareGain. Jim earned a BS from Stanford University and an MBA with distinction from Duke University.
-
A serial entrepreneur who specializes in the startup, acquisition, and development of small and mid-sized companies, Cliff focuses on businesses with unique ideas or technologies that need guidance during their initial growth phases. He is the Director and Entrepreneur in Residence at Columbia Business School.
-
As a practicing oral and maxillofacial surgeon, Dr. Eisig takes great interest in the development and introduction of new clinical modalities that can help many patients requiring craniofacial reconstruction. He is Chief of the Dental Service at NewYork-Presbyterian Hospital, and serves as George Guttmann Professor of Clinical Craniofacial Surgery and Director of Oral and Maxillofacial Surgery. Dr. Eisig has overseen and/or performed all EpiBone’s large-animal preclinical implantations to date.
-
Dr. Cole is an orthopedic sports medicine surgeon at Midwest Orthopaedics at Rush, and a Professor of Orthopaedics, Anatomy and Cell Biology at Rush University Medical Center. He is the head team physician for the Chicago Bulls, and co-team physician for the Chicago White Sox.
-
Dr. Webster brings extensive experience as an FDA pharmacology/toxicology reviewer, regulatory consultant, and leader of regulatory affairs at several cell therapy biotech companies, as well as Quintiles and Cardinal Health. She is highly skilled in regulatory submissions, agency interactions, and providing strategic guidance for drug and biologic development.
-
Dr. Fortier is the Editor-in-Chief of the American Veterinary Medical Association and former James Law Professor of Surgery at Cornell University. Her research focuses on equine orthopedic surgery, arthritis, and regenerative medicine, including PRP, stem cells, and IRAP. She has authored over 250 scientific papers and book chapters and was Editor-in-Chief of the Journal of Cartilage and Joint Preservation. Her work bridges clinical and translational advancements in orthopedics and regenerative therapies.
-
Dr. Bapat, a Medical Doctor specializing in Clinical Pathology, has over 20 years of leadership experience as a Medical Director, PI, and Vice-President across the USA, UAE, India, and Australia. She has managed complex diagnostic labs, regenerative medicine facilities, and gene and cell therapy companies, successfully designing and overseeing clinical trials.
featured investors
Our investors are more than funders. They are thought partners—essential team members who actively participate in shaping our success.
